A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.
A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.
复制标题
DOI:
10.1016/j.neuroimage.2017.03.057
复制
发表时间:
2017-07-15
期刊:
影响因子:
5.7
通讯作者:
Davatzikos C
中科院分区:
文献类型:
--
作者:
Rathore S;Habes M;Iftikhar MA;Shacklett A;Davatzikos C
Neuroimaging has made it possible to measure pathological brain changes associated with Alzheimer’s disease (AD) in vivo. Over the past decade, these measures have been increasingly integrated into imaging signatures of AD by means of classification frameworks, offering promising tools for individualized diagnosis and prognosis. We reviewed neuroimaging-based studies for AD classification and mild cognitive impairment, selected after online database searches in Google Scholar and PubMed (January, 1985 to June, 2016). We categorized these studies based on the following neuroimaging modalities (and sub-categorized based on features extracted as a post-processing step from these modalities): i) structural magnetic resonance imaging [MRI] (tissue density, cortical surface, and hippocampal measurements), ii) functional MRI (functional coherence of different brain regions, and the strength of the functional connectivity), iii) diffusion tensor imaging (patterns along the white matter fibers), iv) fluorodeoxyglucose positron emission tomography (metabolic rate of cerebral glucose), and v) amyloid-PET (amyloid burden). The studies reviewed indicate that the classification frameworks formulated on the basis of these features show promise for individualized diagnosis and prediction of clinical progression. Finally, we provided a detailed account of AD classification challenges and address some future research directions.
登录
查看更多内容
影响因子:
5.7
作者:
Bron EE;Smits M;van der Flier WM;Vrenken H;Barkhof F;Scheltens P;Papma JM;Steketee RM;Méndez Orellana C;Meijboom R;Pinto M;Meireles JR;Garrett C;Bastos-Leite AJ;Abdulkadir A;Ronneberger O;Amoroso N;Bellotti R;Cárdenas-Peña D;Álvarez-Meza AM;Dolph CV;Iftekharuddin KM;Eskildsen SF;Coupé P;Fonov VS;Franke K;Gaser C;Ledig C;Guerrero R;Tong T;Gray KR;Moradi E;Tohka J;Routier A;Durrleman S;Sarica A;Di Fatta G;Sensi F;Chincarini A;Smith GM;Stoyanov ZV;Sørensen L;Nielsen M;Tangaro S;Inglese P;Wachinger C;Reuter M;van Swieten JC;Niessen WJ;Klein S;Alzheimer's Disease Neuroimaging Initiative
通讯作者:
Alzheimer's Disease Neuroimaging Initiative
影响因子:
5.7
作者:
Arbabshirani MR;Plis S;Sui J;Calhoun VD
通讯作者:
Calhoun VD
DOI:
10.1109/tbme.2015.2404809
发表时间:
2015-07
期刊:
IEEE transactions on bio-medical engineering
影响因子:
--
作者:
Cheng B;Liu M;Zhang D;Munsell BC;Shen D
通讯作者:
Shen D
影响因子:
14
作者:
Brookmeyer, Ron;Johnson, Elizabeth;Arrighi, H. Michael
通讯作者:
Arrighi, H. Michael
影响因子:
7.7
作者:
Cabral, Carlos;Morgado, Pedro M.;Silveira, Margarida
通讯作者:
Silveira, Margarida